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Over the last sixty years advances have been made in the control of schistosomiasis in P.R. China. There are,
however, difficult challenges still to be met. This paper looks at the extent to which the health system offers a
positive environment for the control of the disease. It starts by tracing three phases in schistosomiasis control:
disease elimination strategy through snail control (1950s-early 1980s); morbidity control strategy based on
chemotherapy (mid 1980s to 2003); integrated control strategy (2004+). Each one of these phases took place in
distinct policy-making environments. The paper partly draws on these phases to set out five issues of disease
control and discusses them in the context of the health system and its recent trends. These cover the
policy-making process, intersectoral action for health, equity and access to health services, funding for public goods
and externalities, and strengthening resource management and planning. These issues form the basis of an agenda
for integrating research and capacity strengthening in the Chinese health system with a view to creating a more
positive enabling environment for schistosomiasis control. In so doing it is important to emphasize the role and
integrity of the public sector against its commercialization, the underlying value of equity, a systems wide
perspective, and the role of advocacy.
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Schistosomiasis japonica is mainly prevalent in People’s
Republic of China (P.R. China), the Philippines and small
pockets of Indonesia, although P.R. China is the most
heavily endemic of the three countries [1,2]. A large-scale
epidemiological survey at the beginning of 1950s found
that the disease was endemic in 10 provinces, one au-
tonomous region and one municipality (city) mainly
along the Yangtze River in the south of China [3]. It was
estimated that 11.6 million people were infected with
schistosomes and more than 100 million people were at
risk of infection in the 1950s. There were 1.2 million
infected cattle and the habitat area of Oncomelania
hupensis, the intermediate host snails of S. japonicum,* Correspondence: Shenglan.tang@duke.gov
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reproduction in any medium, provided the orreached 14.3 billion m2. A great deal has been achieved
in controlling schistosomiasis in P.R. China [1,4,5]. Be-
tween 1985 and 1995 disease transmission was inter-
rupted in five provinces namely Guangdong, Shanghai,
Fujian, Guangxi, and Zhejiang. By 2010, three provinces -
Sichuan, Yunnan, and Jiangsu - reached the criteria of
transmission control (both human and livestock preva-
lence less than 1%). Four other provinces characterized
with complicated environments and easily affected by the
water level of the Yangtze River- Hubei, Hunan, Jiangxi
and Anhui - reached the criteria of infection control in
2008 (both human and livestock prevalence less than
5%). The number of infected cases has been reduced by
over 97% since the 1950s, reaching the lowest historic
level of 325,824 infections in 2010 [6]. The area of Onco-
melania hupensis habitats was estimated to be 3.7 billion
m2 which is about 25% of that in 1950s [7].
Having noted the above achievements, there are still
many major challenges such as the existing extensive
snail habitats with complicated environments, ecosystem
changes caused by the construction of the Three Gorges
Dams and the South–north Water Conversion Project,Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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sitive surveillance and response system, and the access of
infected persons to health care. This paper analyses the
extent to which one of the keys to understand these chal-
lenges rests not only in the confines of the Schistosomia-
sis Diseases Control programme, but in the rest of the
health system.
How diseases control programmes fit into health sys-
tems has been a recurrent theme of health systems ana-
lysis for many years. The debate over the vertical and/or
horizontal nature of disease control programmes has oc-
cupied an important place in health systems analysis, to-
gether with discussions over the nature of integration
and the specific circumstances in which integration is or
is not appropriate [8-11]. Recent work has also looked to
develop a more synergistic interrelationship between dis-
ease control programmes and the rest of the health sys-
tem in addition to a more systems approach [12-15].
This paper comes within this line of analysis and focuses
on a particular aspect; namely the extent to which the
health system as a whole provides a positive environ-
ment for the effective development of disease control. It
is based on a review of existing research, the analysis of
which takes into account the research and practical ex-
perience of the authors.
Following this introduction, the paper identifies the
historical phases in the control of schistosomiasis in P.R.
China. The phases operated in specific political and so-
cial contexts and exhibited particular approaches to
disease control. This leads to a consideration of an ‘en-
abling environment’ that we judge to significantly further
disease control. On this basis, our analysis explores the
extent to which the health system does or does not meet
the needs of this ‘enabling environment’. Attention is
paid to the policy-making process, intersectoral action
for health, equity and access to health services, funding
for public goods and services, and strengthening re-
source management and planning. Where appropriate,
recommendations for an agenda of health systems re-
search and development will be made. The paper con-
cludes by analysing four emerging themes; the role and
integrity of the public sector, the importance of equity
for infectious diseases of poverty, the significance of
health systems development, and the importance of ad-
vocacy. The paper is aimed at researchers, policy-makers
and practitioners concerned with both schistosomiasis
control and health systems development. It also suggests
a line of analysis that can be developed in the analysis of
other infectious diseases and their control, such as TB,
malaria and HIV/AIDS.
Schistosomiasis and its control in P.R. China
Schistosomiasis was one of the serious infectious dis-
eases at the time of the founding of the P.R. China in1949. Many famous terms, such as “Village without villa-
gers” “Widows villages”, and “Big-belly village”, were
used to describe the devastating consequences the dis-
ease brought to the Chinese people, especially the poor
[3]. Since the 1950s China has been fighting the disease;
strategies and approaches have evolved in a context of
political, socio-economic, technological and epidemio-
logical change. Three relatively distinct phases may be
identified in the process of disease control: a) 1950s to
early 1980s, b) mid-1980s to about 2003, c) from 2004
onwards. In identifying these phases we recognise a de-
gree of generalisation in the analysis together with the
overlapping nature of the phases. Each phase not only
possesses an emphasis on certain approaches to disease
control but relates to a policy environment of political
and social change.
Disease elimination strategy with an emphasis on snails
control (1950s to early 1980s)
Confronted by the poor state of health in P.R. China and
with schistosomiasis as one of the main infectious dis-
eases, there was strong political will among the leaders
of the new republic to control the disease. However, the
financial and human resources for healthcare in P.R.
China were very limited, and most of them were distrib-
uted in a few urban cities. The infrastructure of China’s
health systems in most places was poor and not up to
the level of providing appropriate healthcare to the vast
majority of the population. However, cooperation among
different sectors was developed with programs receiving
political support from a high level. In such circum-
stances, the Ministry of Health developed a policy of
“Prevention First” in the 1950s and focused on snail con-
trol. Snail elimination with environmental modification
and mollusciciding was emphasized in combination with
chemotherapy. Mass movements were developed to
mobilize community resources to contribute to the snail
control campaign, through free labour, and local-driven
innovative models for snail elimination. Under the aus-
pices of the Communist Party, the Chinese people, as
well as paramedics, such as barefoot doctors at the vil-
lage level, engaged in disease control programmes. In
the meantime, agricultural engineering and water con-
servancy activities, such as reclaiming wetlands, digging
new ditches and filling the old ones, and changing rice
paddies into dry crops were developed and implemented
as a series of concerted actions to modify the snails’
habitats to be unsuitable for living and breeding.
An important feature of this disease control was the
establishment and the operation of the vertical national
schistosomiasis control programme in the 1950s. From
national to provincial, prefectoral, county and township
levels, anti-schistosomiasis institutions or stations were
set up to take the main responsibility for disease control
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vention and clinical care and working in these specia-
lized organizations reached 17,000 by the mid 1960s, a
powerful workforce fighting against the disease. The na-
tional programme, including these institutes and sta-
tions, was relatively well funded until the late 1970s. As
results of the effective interventions, a large number of
places in P.R. China were free of snails. The prevalence
rate of schistosomiasis and new cases was reduced to a
very low level in the early 1980s, particularly in the east
coastal areas of China.
Morbidity control strategy based on chemotherapy (mid
1980s to about 2003)
China launched its economic reform in 1978, transform-
ing its planned economy into a market one. The collect-
ive economy, based on the commune system in the rural
areas, collapsed. A de facto privatization of agricultural
production, named as “Household responsibility system”
was introduced in 1983–84 in almost all the townships
and villages. Chinese society has undergone profound
changes since the economic reform. While many of
these may be viewed as positive, such as improved living
standards, there are important downsides, such as wor-
sening equity and social justice. The diminished collect-
ive economy in the rural areas meant that the
community-based health insurance schemes, called “Co-
operative Medical Scheme”, collapsed in over 90% of
townships and counties by the middle of the 1980s. Gov-
ernment health facilities received relatively less funding
to cover their operational costs, while they were impli-
citly encouraged to increase service charges to support
the provision of health services. The commercialization
of healthcare has become widespread and common prac-
tice in health facilities in P.R. China while the health pol-
icy of “Prevention First” has to a large extent been
neglected since the economic reform. Service providers
became interested in generating revenues through ser-
vice charges and profits from drug sale to cover costs
and increase their incomes that were often linked to the
level of revenue generation. Although the government
still gave some support for control of schistosomiasis,
but it was limited and could not meet the needs for dis-
ease control. Even the anti-schistosomiasis institutions
and centres were required to generate revenues to cover
partial costs of their operations. Few health facilities in
P.R. China were still interested in engaging in preventive
measures to control schistosomiasis, among other dis-
eases. Furthermore, the mobilization of community
resources for the disease control was no longer easy.
Free labour was no longer available to tackle snail pro-
blems in rural communities, as the township and village
leadership no longer had powers to force farmers to
work on community projects for free. In addition,intersectoral action for health (IAH) became difficult, if
not impossible. Market mechanisms have now come to
dominate production in Chinese society, while the polit-
ical push to promote intersectoral action for health and
social development, which was strong in the planned
economy, has been greatly weakened. By the late 1990s,
some provinces and counties had scaled down the verti-
cal programme and integrated many anti-schistosomiasis
stations into general centre for disease control (CDC)
systems or other disease prevention institutes.
By co-incidence, the WHO expert consultation com-
mittee for schistosomiasis control in 1984 adjusted its
strategy and objectives for schistosomiasis control from
transmission interruption or elimination to morbidity
control in developing countries [16,17]. The new strat-
egy focused on changing people’s behaviour with an ob-
jective to reduce the morbidity and mortality of
schistosomiasis, rather than controlling the transmission
of schistosomiasis completely; it was convinced that it
would be formidably difficult to eliminate or interrupt
the transmission of schistosomiasis without an enor-
mous amount of financial investment in developing
countries. With the support from the World Bank loan
(1992–2001), the implementation of the strategy, em-
phasizing chemotherapy treatment of human being and
livestock, as the main approach, was initiated in 1992
and completed in 2001. Different chemotherapy strat-
egies were carried out in different endemic areas: mass
chemotherapy was used for the people from endemic
areas with a high prevalence and with a history of water
contact. For residents and bovine in areas with medium
endemicity, the treatment was only given to those with
stool egg positive or positives in serological tests. In the
area of low endemicity, only children were screened and
treated, if diagnosed as positive cases. Infected cattle
were also given appropriate treatments under the World
Bank project [18]. The achievement of the World Bank
funded project proved that the chemotherapy based
strategy could decrease the prevalence of schistosomiasis
quickly but that the consolidation task is arduous, as the
areas of snail habitats are still large and fluctuated
greatly in P.R. China [19-21]. Potential transmission
remains considerable in the lake areas. In addition, the
drugs for anti-schistosomiasis was free under the World
Bank project, other costs of healthcare such as drugs for
liver protection, were required to pay out of pocket by
the patients. In the context of lack of appropriate health
insurance schemes put in place, early case detection was
often problematic. In a more general sense, access to
healthcare in P.R. China was worsening in the 1990s, as
seen in a rapid rise of healthcare costs, and increasing fi-
nancial challenges the health insurance schemes in both
urban and rural areas were facing. Following the comple-
tion of the World Bank project, the central government
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tainable control of schistosomiasis, which leading to the re-
surgence of the schistosomiasis transmission after the
World Bank loan project ended [22-24].
Integrated control strategy focusing on interrupting
transmission (2004 –)
Since the late 1990s, the Government of P.R. China has
increasingly recognized the important role the state
should play in developing and strengthening health sys-
tems to improve equitable access to healthcare for the
vast majority of the population. This responded to the
increased inequity in health and healthcare and the
resulting discontent among the public. The outbreak of
SARS in 2003 was another alarm signal to the govern-
ment that public health crises can affect not only health
but also economic growth. Therefore, strengthening
health systems to achieve universal health coverage has
been put on the political agenda. A decision on the re-
establishment of rural health insurance schemes with fi-
nancial support from central government in 2002 was
one of many examples that the government of P.R.
China has once again taken health policies seriously.
Under these circumstances and with the re-emergence
of schistosomiasis at the beginning of 21st century in P.R.
China, schistosomiasis control has once again been given a
high priority. It was recognised that the chemotherapy-
based approach could reduce the prevalence/morbidity to
a low level rapidly. However, the environment of snail habi-
tats would not change much and the opportunities of re-
infection for many at-risk population remained high due to
unchanged agricultural production and people’s life styles
in endemic areas. Hence, a new integrated control strategy
aimed to interrupt transmission based on reducing the rate
of transmission of schistosomiasis infection from cattle and
human being to snails has been developed and adopted by
the national schistosomiasis control programme. The inter-
ventions include agricultural mechanization (to replace the
use of cattle), supplying water, sanitation and lavatories/
latrines, providing boats with faecal-matter containers, plus
routine chemotherapy, moulluscides and health education
[25,26]. These interventions have been made possible,
owing to strong political, policy and financial support given
to the national schistosomiasis control program in recent
years. This forms part of the new health system reform in
which increasing equitable access to public health inter-
ventions is one of top priorities set out by the government.
After several years implementation of the integrated con-
trol strategy, positive achievements have been seen. Four
more provinces have now reached the level of infection
control and three have met the targets of transmission con-
trol [6]. Compared to the situation in 2003, the number of
estimated infected people reduced from 843,000 to
325,824. The number of acute cases decreased from 1,114in 2003 to only 43 in 2010 [6]. The prevalence rate of
infected cattle reduced from 4.1% to 1% over the period.
Such results show that political will and appropriate policy
on effective strategy on schistosomiasis control are critic-
ally important to effective disease control. Equally import-
ant is the strengthening of overall health systems from
national to local level. Marketertization of healthcare, par-
ticularly public health programmes, would not work, espe-
cially in infectious disease control.
Controlling schistosomiasis and the health system
This section will partly build on section 2 by drawing out
and discussing five key issues of schistosomiasis control in
P.R. China and how they relate to the health system. It will
take into account the current trends in the health system
and ask how these affect schistosomiasis control. It will
also provide the grounds for recommending key areas of
research and capacity development in the health system
and in relation to schistosomiasis control.
Although a vertical form of schistosomiasis disease
control programme was set in phase one (see section 2),
there has been a process of integrating the activities of
disease control with the CDC system and the general
health services. A first area of research and policy ana-
lysis therefore is to analyse the extent of that integration,
mapping out how this is expressed in resource gener-
ation and allocation, policy-making and planning, re-
source management, service delivery, and governance.
This may be accompanied by an analysis of the determi-
nants and impact of the diverse forms of integration in
operation [27] and how the analysis of the five factors in
this section would affect the degree of integration.
Policy-making
Section 2 raised important issues about policy-making
for and the prioritising of schistosomiasis control in P.R.
China. It was noted that different strategies of interven-
tion have been used corresponding with the three phases
which, in turn, corresponded with different policy-
making environments. Although the first phase was
characterised by depleted national resources, there was
strong political will to control the disease; a robust verti-
cal disease control programme was developed along with
effective community involvement in transmission con-
trol, and intersectoral action for health. The second
phase occurred in the context of market reform charac-
terised by health care commercialisation and the loss of
intersectoral action for health and community in-
volvement. The phase coincided with a WHO sup-
ported shift to morbidity control through the World
Bank supported project. The third phase constitutes
a reaction to public health crises and the problems
of inequity engendered through market reform and
health care commercialisation.
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sustainability of interventions are certainly critical issues.
These are important given the severity of the disease but
also because it can easily rebound if attention is reduced.
Section 2 emphasised the differences between the high
priority given in the first and third periods and the lesser
priority given in the second period. It goes without say-
ing that policy-making operates in an historical context
and the three phases clearly confirm this. Yet this raises
a challenge to policy-making; how to achieve consistency
and sustainability to undertake the medium to long term
preventive interventions and intersectoral action for
health as a form of disease control that goes beyond the
shorter term political changes and the periodic form of
loan financing. At the same time, the possibility of the
disease to rebound requires a more sophisticated process
of priority setting that relies primarily on the more im-
mediate indicators of mortality and morbidity.
Prioritising schistosomiasis control within the broad
range of health needs and interventions has to go be-
yond the spoken and written word of the policy declar-
ation. Resource allocation has to give a material backing
to the prioritising. Neither can this material backing be
based on the assumption that regions and localities are
able to raise their own funds for diseases control. This is
particularly true for areas of central and western China
which already receive central subsidies for rural health
insurance, among others. Schistosomiasis is more
prevalent in the poorer regions of China; Ross et al.
noted that the disease “. . .remains a major problem in
the marshland and lake areas of Hubei, Hunan, Anhui,
and Jiangxi and in some mountainous areas of Sichuan
and Yunnan” [28]. These are precisely among the regions
of China that particularly require such subsidies and cen-
tral funding.
Lastly, we need to emphasise that schistosomiasis con-
trol requires joint policy-making work across organisa-
tional boundaries and systems. Policy-making needs to
move beyond the confines of the health system, a point
we now pick up under the heading of intersectoral ac-
tion for health.
Intersectoral action for health (IAH)
IAH is clearly important and comes through strongly as an
important requirement of the health system for schisto-
somiasis control. The headlong imperative of economic
growth can lead to growing inequality, poverty and disease
burden. The precipitous implementation of water develop-
ment projects and increased urbanisation has laid the con-
ditions for increasing mortality and morbidity from
schistosomiasis in P.R. China. To undercut the social and
economic conditions of the disease requires a broad polit-
ical perspective that puts the disease on the policy agenda,
brings the disease control into the broader policy processidentifying its social and economic conditions and secures
the links between the disease control and health systems
development. This was clearly more evident in the first
and the third phases outlined in section 2. In the push for
increased mechanisation in agriculture and improved water
and sanitation, the health system needs to play its part in
breaking the barriers within the health system and between
the health and other systems such as agriculture, forestry
and water / sanitation. It requires advocacy by actors
involved with schistosomiasis control through the gener-
ation and presentation of evidence on the social economic
conditions of schistosomiasis, policy analysis on the effect-
iveness and feasibility of interventions, together with net-
working and building coalitions of support for the control
of the disease [29]. There is a need for this advocacy to be
based on the underlying values of effective health interven-
tions through IAH and equity.
An important constraint on IAH in P.R. China is the
inward looking commercial practices of government sec-
tors since the economic reform. Concerned with revenue
growth and surplus generation, little is left for pooling
resources and space for working together. While recent
years have seen improvements in the central coordin-
ation of government actions – through the National
Leading Group for Schistosomiasis Control and the Five
Year Plan for Schistosomiasis Control – there is a need
to monitor and evaluate the effectiveness of these organ-
isational changes in leading to implementation of IAH at
central, regional and local levels.
Equity and access to health services
Schistosomiasis is principally a disease of the poor and
China is far from being an exception in this respect
[22,30-32]. This raises a number of important issues: the
extent to which there is an overall focus in the health
system (and within schistosomiasis control) on equity
and the poor, the social determinants of schistosomiasis
and the impact the disease has on poverty, and the ac-
cess to treatment for the poor. Those infected may use
the Schistosomiasis Control Stations (SCS) although
many of these have been integrated into the Centres of
Disease Control (CDC). Treatment for schistosomiasis
in these facilities is free at the point of delivery. How-
ever, before reaching these facilities, patients often pass
through general health facilities (e.g. village health sta-
tions). There are certainly financial restrictions to access
to these general health facilities for the poor, which can
lead to further transmission of the disease mainly among
the poor. The problem is that Yu et al’s study in 6 vil-
lages of Hunan Province in 2001 found “. . .both the will-
ingness and the amount that people were willing to pay
for treatment were low among villagers in the endemic
areas in this region, especially in heavily endemic areas
where villagers are most affected and have the lowest
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diverse forms of government sponsored health insurance
in P.R. China, regulations on co-payments and ceilings
negatively affect access. Linked to this are cases of rent
seeking behaviour by providers such as supplier induced
demand and mark-ups on medicines. Research into
treatment of TB patients has also shown a certain lack
of interest by general health care providers in referring
patients on to the free care at the SCSs and CDCs, thus
helping their own health care facility to reap the finan-
cial rewards [34]. Whether this occurs in the case of
schistosomiasis needs to be the subject of research.
Funding for public goods and externalities
The control of schistosomiasis requires IAH, interven-
tions that provide public goods and services together
with goods with high externalities. This suggests the im-
portance of appropriate and secure funding for disease
control by the state and based on taxes or similar secure
revenues [35]. These forms of disease control are not ap-
propriate to financing and provision through private
markets or commercialised public provision. The com-
mercialisation of the health system in recent decades
raises critical issues for schistosomiasis control in P.R.
China. Restrictions and relative decreases in government
budget allocations to health facilities, the increased de-
pendence on user fees and insurance payments, the use
of staff bonus schemes in health facilities based on treat-
ment, the move from prevention to more revenue earn-
ing curative services, and the emergence of supplier
induced demand raise serious doubts over the compati-
bility of schistosomiasis control and commercialisation
of the public sector in P.R. China [35]. In theory, CDC
and similar preventive institutions in P.R. China should
be fully funded by the government. In reality, however, a
vast majority of CDC need to raise some fund through
service charges in order to cover partial operational
costs and increase bonus payments to their staff. A key
issue here is the need to develop general funding
mechanisms based on tax bases and centrally or region-
ally allocated to affected regions to allow for the
provision of public goods and preventive interventions
required in the control of schistosomiasis.
Strengthening resource management and planning
Complementing the four previous factors of health sys-
tems development, there are a number of key areas in
which the management and planning of resources need
strengthening. These include surveillance and monitor-
ing, human resource development for both specialist re-
search and development in schistosomiasis control and
the training of general health staff in the disease control,
and the supply systems for delivering medicines. Moni-
toring the effectiveness of implementing schistosomiasiscontrol is a key challenge. There are two important areas
for development: firstly, there is the need to ensure tar-
gets met with the delivery of high quality services, and
secondly, to ensure efficiency in resource utilisation. An-
other most important issue is how to improve positive
synergies of combining the local resources with the fund
from the central government. Some interventions, such
as mollusciciding, chemotherapy of local residents and
bovines, and faecal management need appropriate re-
source pooling to increase the population coverage,
while some engineering related interventions, such as
agriculture irrigation system modification, altering the
crops planting, biogas station should pool resources
from different channels in an effective way. The high
cost-effectiveness for a specific strategy in the either ver-
tical or integrated control program relies on good re-
source management. In the current status of P.R. China,
it is essential for the national control programme in P.R.
China to be part of the push for universal coverage of
health care in order to ensure sustainable control of
schistosomiasis in P.R. China.
Moving forward to health systems development
The five issues featured in the previous section constitute
an agenda for integrated research and capacity strengthen-
ing in health systems with a view to schistosomiasis con-
trol. Applied research should increase our understanding
of the health system needs of schistosomiasis control, while
development strengthens the capacity of the health system
to meet the needs of disease control. In so doing, there are
four important considerations.
a) An important theme running through this paper is
to shift away from the commercialisation of the
public sector and move towards strengthening of the
role and integrity of the public sector in
schistosomiasis disease control. This is apparent in
the strengthening of policy-making in government,
intersectoral action for health, the importance of
equity as a key value, the access to treatment, the
provision of public goods and the strengthening of
resource management and planning. These need
to be broken down into specific measures, such as
strengthening surveillance systems, urban and
rural health insurance, and funding for public
goods and services.
b) An underlying value of the whole approach to the
control of schistosomiasis is that of equity. On
the one hand, this requires a reaffirmation of
public service values around health systems based
on improved and more equitable health and
health care. On the other, it is a disease of
poverty, the control of which needs to get to the
foundations of that poverty.
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areas should not lead to isolation of specific forms of
disease control. Many of these features of disease
control hold for other diseases. At the same time,
care needs to be taken in dealing with these issues in
a system wide perspective. For example, setting the
priority of schistosomiasis control in policy-making
and resource control needs to be seen in the context
of general health needs and general health planning.
The exercise of health needs identification needs to
be done across the full spectrum of infectious disease
of poverty and, in fact, the overall health needs of a
society. The exercise conducted in this paper needs
to be one of many exercises in disease control and in
which health systems change is responding to health
needs of a population.
d) Lastly, we return to advocacy. It is anticipated that
the discussion of this and other likeminded papers
should lead to ‘a health systems agenda for
schistosomiasis control’. Such an agenda needs to
coalesce around a coalition of stakeholders; those
support of sufferers of the disease, researchers from
diverse disciplines, technical experts, politicians,
health managers and planners, and service providers.Additional file
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